Join the Chronic Migraine group to help and get support from people like you.
Chronic Migraine News (Page 2)
Related terms: Migraine, Chronic
What Factors Really Predict Migraine Onset?
THURSDAY, Jan. 25, 2024 – Factors like sleep, energy levels and stress can predict the onset of a migraine headache, a new study finds. Those factors differed from the morning to the afternoon and...
>30 Percent With Migraine Experience Migraine-Related Stigma Often
THURSDAY, Jan. 18, 2024 – More than 30 percent of individuals with migraine experience migraine-related stigma often or very often, according to a study published online Jan. 17 in Neurology. Robert...
Eye Blood Flow Could Be Marker for Migraine
WEDNESDAY, Jan. 17, 2024 – Blood flow appears to be reduced in the eye during migraine attacks, according to a study published online Nov. 30 in Headache: The Journal of Head and Face Pain. ...
Motor Vehicle Crashes Increased in Year After Incident Migraine Among Seniors
MONDAY, Jan. 8, 2024 – For older adults, the likelihood of motor vehicle crashes (MVCs) is increased in the year after incident migraine, according to a study published online Dec. 22 in the Journal...
Migraines Could Raise Crash Risks for Older Drivers
FRIDAY, Jan. 5, 2024 – Migraines are not only extremely painful, but they also appear to pose a driving risk for seniors, a new study warns. Older adult drivers recently diagnosed with migraines are...
Study Compares Effectiveness of Migraine Preventive Drugs
FRIDAY, Dec. 22, 2023 – For patients with migraine, simvastatin, calcitonin gene-related peptide pathway antibodies (CGRPabs), and amitriptyline have a favorable effect compared with beta blockers,...
Migraine? Reach for Prescription Meds, Not Ibuprofen
THURSDAY, Nov. 30, 2023 – Migraine sufferers would do better to talk to their doctor about a prescription drug than reaching for a bottle of ibuprofen, a new study finds. Drugs like triptans, ergots...
Triptans, Ergots, Antiemetics Most Effective Meds for Migraine
WEDNESDAY, Nov. 29, 2023 – Triptans, ergots, and antiemetics are the most effective classes of medications for migraine, according to a study published online Nov. 29 in Neurology. Chia-Chun Chiang,...
Ubrogepant Beneficial for Treating Migraine During the Prodrome
WEDNESDAY, Nov. 22, 2023 – Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D.,...
Adverse Childhood Experiences Linked to Headache in Adulthood
FRIDAY, Oct. 27, 2023 – Adverse childhood experiences (ACEs) are associated with primary headache in adulthood, according to a review published online Oct. 25 in Neurology. Claudia Sikorski, Ph.D.,...
Growing Pains May Be Precursor to Migraine
MONDAY, Sept. 11, 2023 – Growing pains (GP) among children and adolescents may be a precursor to or comorbidity with migraine, according to a study published online Sept. 6 in Headache. Raimundo...
'Magic Mushroom' Drug Psilocybin Shows Early Promise in Easing Migraines
MONDAY, Aug. 14, 2023 – Psilocybin, the active ingredient in "magic" mushrooms, is getting renewed interest as a potential treatment for various health conditions. Now, a new research review argues...
Gadolinium-Enhanced MRI Can Differentiate Meniere From Vestibular Migraine
MONDAY, Aug. 7, 2023 – Gadolinium-enhanced magnetic resonance imaging (MRI) of the inner ear can help differentiate Meniere's disease (MD) from vestibular migraine (VM), according to a study...
Vestibular Function Tests ID Vestibular Migraine Versus Meniere Disease
FRIDAY, July 7, 2023 – Vestibular symptoms and results from vestibular function tests may differentiate between vestibular migraine (VM) and Meniere disease (MD), according to a study published in...
U.S. FDA Approves Qulipta (atogepant) for Adults With Chronic Migraine
NORTH CHICAGO, Ill., April 17, 2023 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved expanding the indication of Qulipta (atogepant) ...
Ask a question
To post your own question to this support group, sign in or create an account.